Year-end Sale % OFF 
Abstract
Background and Aim: Non Alcoholic Fatty Liver Disease (NAFLD) is the hepatic manifestation of metabolic syndrome. Patients with NALFD also have increased endothelial dysfunction, coronary artery calcification and increased arterial stiffness which risks higher occurrence of coronary events.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
